Palatin Technologies Inc. (PTN)

May 01, 2026

PTN Stock Price, Quote & Chart | PALATIN TECHNOLOGIES INC (NYSEARCA:PTN) - ChartMill

May 01, 2026

Apr 24, 2026

PTN Technical Analysis | Trend, Signals & Chart Patterns | PALATIN TECHNOLOGIES INC (NYSEARCA:PTN) - ChartMill

Apr 24, 2026

Apr 23, 2026

AuGC reports 94,212-share stake in Palatin Technologies (PTN) - Stock Titan

Apr 23, 2026

Apr 20, 2026

Palatin Technologies (PTN) Stock: Momentum Signals (Modest Decline) 2026-04-20Social Investment Platform - Cổng thông tin điện tử tỉnh Tây Ninh

Apr 20, 2026

Apr 16, 2026

Q1 2026 Palatin Technologies Inc Earnings Call Transcript - GuruFocus

Apr 16, 2026

Apr 15, 2026

Palatin Technologies, Inc. (PTNT) - Minichart

Apr 15, 2026

Apr 13, 2026

How does Palatin Technologies (PTN) Stock react to market crashes | Price at $18.00, Down 0.11%Dividend Growth - Newser

Apr 13, 2026

Apr 12, 2026

Palatin Technologies, Inc. (PTN) - Minichart

Apr 12, 2026

Apr 09, 2026

Analysts Are Bullish on These Healthcare Stocks: GE Healthcare Technologies Inc (GEHC), Nuvation Bio (NUVB) - The Globe and Mail

Apr 09, 2026

Apr 07, 2026

PTN PE Ratio & Valuation, Is PTN Overvalued - Intellectia AI

Apr 07, 2026

Apr 02, 2026

PTN Technical Analysis & Stock Price Forecast - Intellectia AI

Apr 02, 2026

Mar 28, 2026

Palatin Technologies (PTNT) Short Interest & Short Float | Updated Apr 2026 $PTNT - MarketBeat

Mar 28, 2026

Mar 22, 2026

Palatin Technologies stock faces volatility amid bremelanotide sales updates and pipeline advancemen - AD HOC NEWS

Mar 22, 2026

Mar 21, 2026

Palatin’s Case Strengthens as Rhythm’s FDA Approval Validates Hypothalamic Obesity Market (PTN) - The Globe and Mail

Mar 21, 2026

Mar 20, 2026

Palatin Technologies (PTNT) Insider Trading Activity 2026 $PTNT - MarketBeat

Mar 20, 2026

Mar 18, 2026

Palatin Technologies (PTNT) 10K Form and SEC Filings 2026 $PTNT - MarketBeat

Mar 18, 2026

Mar 17, 2026

PTN Earnings History & Surprises | EPS & Revenue Results | PALATIN TECHNOLOGIES INC (NYSEARCA:PTN) - ChartMill

Mar 17, 2026

Mar 13, 2026

PTN Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Mar 13, 2026

Mar 04, 2026

Operating cash flow per share of Palatin Technologies, Inc. – LSE:0KF3 - TradingView

Mar 04, 2026

Mar 04, 2026

EBIT per share of Palatin Technologies, Inc. – LSE:0KF3 - TradingView

Mar 04, 2026

Mar 02, 2026

Dry Eye Disease Market: Rapid Increment Driven by Innovation by 2034 – DelveInsight | Palatin Technologies, Novaliq, mc2 therapeutics - Barchart.com

Mar 02, 2026

Feb 27, 2026

PTN Should I Buy - Intellectia AI

Feb 27, 2026

Feb 26, 2026

Palatin Techs (PTN) Stock Analysis Report | Financials & Insights - Benzinga España

Feb 26, 2026

Feb 21, 2026

Palatin Technologies (PINK:PTNT) Share Price Crosses Above 200-Day Moving Average – Here’s What Happened - Defense World

Feb 21, 2026

Feb 19, 2026

Palatin to test 2 obesity-targeting drugs for PWS in clinical trials this year - Prader-Willi Syndrome News

Feb 19, 2026

Feb 19, 2026

Palatin Technologies Q2 Earnings Call Highlights - Defense World

Feb 19, 2026

Feb 19, 2026

Palatin Technologies’ Rare-Obesity Strategy Sets Up a Catalyst-Rich 2026 for Its MC4R Pipeline (NYSE: PTN) - The Globe and Mail

Feb 19, 2026

Feb 18, 2026

Palatin Technologies, Inc. (AMEX:PTN) Q2 2026 Earnings Call Transcript - Insider Monkey

Feb 18, 2026

Feb 18, 2026

Palatin Technologies' Rare-Obesity Strategy Sets Up a Catalyst-Rich 2026 for Its MC4R Pipeline (NYSE: PTN) - TradingView

Feb 18, 2026

Feb 18, 2026

Earnings call transcript: Palatin Technologies Q2 2026 reveals challenges By Investing.com - Investing.com South Africa

Feb 18, 2026

Feb 17, 2026

Palatin Technologies Inc (PTN) Q2 2026 Earnings Call Highlights: Strategic Advances Amid Rising Losses - GuruFocus

Feb 17, 2026

Feb 17, 2026

Earnings call transcript: Palatin Technologies Q2 2026 reveals challenges - Investing.com Australia

Feb 17, 2026

Feb 17, 2026

PTN: Strengthened cash position and advanced rare obesity pipeline with key clinical milestones ahead - TradingView

Feb 17, 2026

Feb 17, 2026

PALATIN TECHNOLOGIES INC SEC 10-Q Report - TradingView

Feb 17, 2026

Feb 17, 2026

Palatin Reports Second Quarter Fiscal Year 2026 Financial Results and Provides Corporate Update - The Malaysian Reserve

Feb 17, 2026

Feb 17, 2026

PTN | Palatin Technologies, Inc. Analyst Forecasts - Quiver Quantitative

Feb 17, 2026

Feb 17, 2026

PTN | Palatin Technologies, Inc. Insider Trading - Quiver Quantitative

Feb 17, 2026

Feb 17, 2026

Palatin Technologies Q2 revenue rises yr/yr, net loss widens - TradingView

Feb 17, 2026

Feb 17, 2026

PTN: MC4R obesity programs advance to clinical trials as cash position strengthens and net loss widens - TradingView

Feb 17, 2026

Feb 17, 2026

Palatin funds new obesity drug trials for hypothalamic obesity, PWS - Stock Titan

Feb 17, 2026

Feb 16, 2026

Palantin Technologies to enact 1-for-50 reverse stock split - MSN

Feb 16, 2026

Feb 08, 2026

Head-To-Head Contrast: Palatin Technologies (PINK:PTNT) vs. Akorn (OTCMKTS:AKRXQ) - Defense World

Feb 08, 2026

Jan 26, 2026

Calliditas Therapeutics AB (publ) (NASDAQ:CALT) & Palatin Technologies (PINK:PTNT) Critical Analysis - Defense World

Jan 26, 2026

Jan 20, 2026

Palatin initiated with a Buy at LaidlawRhythm Pharmaceuticals - MSN

Jan 20, 2026

Jan 20, 2026

The Truth About Palatin Technologies (PTN): Tiny Biotech, Huge Hype – But Is It Worth Your Money? - AD HOC NEWS

Jan 20, 2026

Jan 15, 2026

Palatin Technologies (PINK:PTNT) Stock Price Passes Above 200-Day Moving Average – Time to Sell? - Defense World

Jan 15, 2026

Jan 12, 2026

Palatin Technologies Targets Hypothalamic Obesity as Next Frontier Beyond GLP-1s (NYSE: PTN) - TradingView — Track All Markets

Jan 12, 2026